The Europe Nootropics Market would witness market growth of 13.9% CAGR during the forecast period (2021-2027).
Nerves are responsible for the movement of the body, and any kind of problem between the communication of nerves and the brain can result in a variety of brain health problems. Nootropic pills can help reduce the discomfort associated with a variety of neurological diseases by preserving nerves from any damage.
They may also help with neuropathy symptoms including numbness and tingling. As nerves helps in coordination of the body and enhance performance of numerous body parts, people opt for nootropics for enhanced motor function.
Synthetic nootropics, such as piracetam, are made in a lab, but natural nootropics, such as Ginkgo biloba and Panax quinquefolius, are found in herbal plants. These nootropics work as vasodilators in the brain's tiny arteries and veins. In addition, they reduce inflammatory responses in the brain.
In Germany, nootropics are considered to be safe for consumption. There is increasing cases of mental illness and the growing demand for various functional food and beverages across this region. Psychosis cases have surged in England over the last two years since number of people suffering from hallucinations and delusion is increasing owing to the Covid-19 pandemic. There is a 29% surge in the number of people went for mental health services for their initially suspected psychosis in April 2021, according to NHS.
The Germany market dominated the Europe Nootropics Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $1.6 billion by 2027. The UK market would witness a CAGR of 13.1% during (2021 - 2027). Additionally, The France market is anticipated to grow at a CAGR of 14.7% during (2021 - 2027).
Based on Distribution Channel, the market is segmented into Offline and Online. Based on Form, the market is segmented into Capsules/Tablets, Powder, Drinks, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Nootropics Market Size will Hit $24.6 Billion by 2027, at a CAGR of 14.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Mental Mojo, LLC, Onnit Labs, Inc., Peak Nootropics (Advanced Nootropics), Reckitt Benckiser Group PLC, Mind Lab Pro (Opti-Nutra, ltd.), Zhou Nutrition LLC (Nutraceutical International Corporation)TruBrain, Wolfson Holdco Limited (NooCube), NEU MIND, LLC, and Kraken Koffee, LLC.
By Distribution Channel
By Form
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 